Athero Review - Issue 2/2020

Editorial

71
Editorial

Michal Vrablík


72
Opustil nás profesor Milan Šamánek

Michal Vrablík


Guidelines

76
Therapy with drugs containing the active ingredient LOMITAPIDE in patients with homozygous form of familial hypercholesterolemia: a statement of the committee of the Czech Society for Atherosclerosis

Vladimír Bláha, Michal Vrablík, Vladimír Soška, Jan Piťha, Renata Cífková, Tomáš Freiberger, David Karásek, Pavel Kraml, Hana Rosolová, Tomáš Štulc, Zuzana Urbanová Za Výbor Čsat


83
How media affect fat choice

Jiří Brát

88
Genetic testing for early prediction of cardiovascular diseases: genome-wide association studies and polygenic score

Jaroslav A. Hubáček

93
Very low LDL cholesterol in acute coronary syndrome

Jan Piťha

99
Cardiovascular risk in patients with familial hypercholesterolemia. Do we rate it correctly?

Ubomíra Fábryová

107
Psychosocial cardiovascular risk factors

Jan Bruthans


113
Combined hypolipidemic therapy: case report

Marcel Nesva, Patrik Christian Cmorej, David Peřan, Jaroslav Pekara


117
LipitenCliDec Study – the profile of patients with uncontrolled arterial hypertension and/or dyslipidemia in primary care in the Czech Republic: the 2nd phase results

Martin Šatný, Eva Tůmová, Michal Vrablík, Jana Mašková, Jiří Laštůvka

124
New findings about alirocumab therapy from the common conference of the American College of Cardiology and the World Congress of Cardiology 2020

Ivan Tkáč


127
The timing for CV risk intervention as a critical success factor

Zuzana Zafarová, Michal Vrablík


131
Rešerše zajímavých článků ze zahraniční literatury

Eva Tůmová


133
Interaktivní webinář: 1. díl – Kardiovaskulární prevence a diabetes

Kristýna Čillíková


Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account